44 results
8-K
EX-1.1
EQ
Equillium Inc
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
described in the Registration Statement and the Prospectus. The descriptions of the Company’s stock option, stock bonus and other stock plans
PRE 14A
EQ
Equillium Inc
31 Mar 23
Preliminary proxy
4:02pm
a market comparison analysis to assist with evaluating salary, bonus and equity compensation for our executives, including our named executive officers … in evaluating and approving salary, bonus and equity compensation decisions for our named executive officers for 2022. The publicly-traded peer
424B3
l7o8k
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
8rudpi7s3qxhin0wn
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
7nifa1ejwwoz 5s7cr
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
wibnux
26 Sep 22
Business combination disclosure
5:29pm
8-K
EX-99.3
hio2bj j5q3idzj
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
8kawgshf
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
lckm8mmgzsx88fjq9gig
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-2.1
2ybtb0 p3cfaorhvrpz
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
0bdmlhj
21 Dec 20
Equillium Appoints Industry Veteran, Dolca Thomas, M.D. as Executive Vice President of
8:06am